Shares of Knight Therapeutics Inc. (TSE:GUD – Get Free Report) hit a new 52-week high on Tuesday . The company traded as high as C$6.56 and last traded at C$6.56, with a volume of 69474 shares trading hands. The stock had previously closed at C$6.44.
Knight Therapeutics Price Performance
The company has a debt-to-equity ratio of 7.52, a current ratio of 3.36 and a quick ratio of 1.79. The stock has a market cap of C$651.34 million, a price-to-earnings ratio of -164.00, a P/E/G ratio of -1,013.50 and a beta of -0.02. The stock has a fifty day moving average of C$6.00 and a 200 day moving average of C$6.07.
About Knight Therapeutics
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company’s principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.
Read More
- Five stocks we like better than Knight Therapeutics
- Elon Musk already made me a “wealthy man”
- Elon’s Secret AI Partner?
- Silver $500? The “Deficit Math” says it’s possible.
- Elon Musk: This Could Turn $100 into $100,000
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Knight Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Knight Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
